Our key areas of interest are: respiratory disease, cardiovascular disease, HIV, Parkinson's disease, thromboembolic disease, cerebrovascular disease and depression We are one of the top 20 leading pharmaceutical companies in the world In 2008, worldwide, we had sales of €11.6 billion; while spending one fifth of net sales in our largest business segment Prescription Medicines on research and development